Where indicated, cells were treated with 10 µM MG-132, 2 µM bortezomib, or 10 nM rapamycin (all from Enzo Life Sciences) at 1 hpi. To inhibit autophagy and lysosomal degradation, cells were incubated with 10 µM spautin-1 or 1 µM BA-1 (all from Sigma-Aldrich) 1 h before infection.
Bortezomib
Bortezomib is a proteasome inhibitor used in research applications. It functions by inhibiting the 26S proteasome, a large protein complex responsible for the degradation of most cellular proteins.
Lab products found in correlation
5 protocols using bortezomib
Dendritic Cell Infection Dynamics
Where indicated, cells were treated with 10 µM MG-132, 2 µM bortezomib, or 10 nM rapamycin (all from Enzo Life Sciences) at 1 hpi. To inhibit autophagy and lysosomal degradation, cells were incubated with 10 µM spautin-1 or 1 µM BA-1 (all from Sigma-Aldrich) 1 h before infection.
Culturing T-ALL Cell Lines
Evaluating Compound-Induced Cell Death
Proteasome Immunoprecipitation from Sciatic Nerve
Immunoprecipitation of p53 Protein
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!